NextPoint Therapeutics
Cambridge, MA
NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.
nextpointtx.comCompany Details
Founded
- 2020
Employees
- Between 20 - 50 employees
Raised
- $122,500,000
Headquarters Location
- Cambridge, MA
Public
- No
Acquired
- No
CEO
Ivan Cheung
Founders
- Gordon FreemanXingxing Zang
Company Collections
These are collections NextPoint Therapeutics is a part of. Click on the collection name to view similar companies.
NextPoint Therapeutics' Industries
NextPoint Therapeutics Headquarters Location
238 Main Street 5th Floor, Cambridge, MA 02142
Total Amount Raised: $122,500,000
NextPoint Therapeutics Funding Rounds
Series B
$42,500,000
Series B Investors
Catalio Capital ManagementMPM CapitalSanofi-AventisSixty Degree CapitalBinney Street CapitalWTT InvestmentGordon FreemanArkin HoldingsInvusLeaps by BayerSeries B
$80,000,000
Series B Investors
Leaps by BayerSanofi-AventisPagodaTree PartnersGordon FreemanSixty Degree CapitalMPM CapitalInvusBinney Street CapitalCatalio Capital Management
Funding info provided by Diffbot.
NextPoint Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on NextPoint Therapeutics.